​

BridgeBio Pharma Ownership | Who Owns BridgeBio Pharma?

OverviewForecastRevenueFinancialsChart

BridgeBio Pharma Ownership Summary

BridgeBio Pharma is owned by 90.83% institutional investors, 5.40% insiders, and 3.77% retail investors. Kohlberg kravis roberts is the largest institutional shareholder, holding 16.56% of BBIO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.38% of its assets in BridgeBio Pharma shares.

BBIO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockBridgeBio Pharma90.83%5.40%3.77%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Kohlberg kravis roberts31.06M16.56%$786.77M
Viking global investors lp25.12M13.39%$636.31M
Vanguard group14.05M7.49%$356.01M
Blackrock12.45M6.64%$315.31M
Aisling capital management lp6.07M3.23%$153.71M
State street5.85M3.12%$148.29M
Laurion capital management lp4.39M2.34%$111.17M
Janus henderson group4.31M2.30%$109.29M
Frazier life sciences management3.63M1.94%$92.01M
Geode capital management3.29M1.75%$83.36M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Aisling capital management lp6.07M66.52%$153.71M
Kohlberg kravis roberts31.06M23.60%$786.77M
Superstring capital management lp219.84K7.02%$5.57M
Prosight management, lp800.00K6.06%$20.26M
Frazier life sciences management3.63M4.30%$92.01M
M28 capital management lp121.20K3.98%$3.07M
Octagon capital advisors lp690.00K2.75%$17.48M
Cormorant asset management, lp1.86M2.72%$47.07M
Ikarian capital6.00K2.65%$15.20M
Viking global investors lp25.12M2.45%$636.31M

Top Buyers

HolderShares% AssetsChange
Blackrock12.45M0.01%1.98M
Janus henderson group4.31M0.06%999.83K
Norges bank893.73K0.00%893.73K
Vanguard group14.05M0.01%832.62K
Susquehanna group, llp676.65K0.00%618.30K

Top Sellers

HolderShares% AssetsChange
Lord, abbett---2.80M
Cormorant asset management, lp1.86M2.72%-1.34M
Perceptive advisors---1.22M
Paradigm biocapital advisors lp---1.09M
Laurion capital management lp4.39M1.32%-787.46K

New Positions

HolderShares% AssetsChangeValue
Norges bank893.73K0.00%893.73K$22.64M
Twinbeech capital lp341.25K0.17%341.25K$8.64M
Melqart asset management (uk)307.91K0.65%307.91K$7.80M
Balyasny asset management207.28K0.01%207.28K$5.25M
Susquehanna fundamental investments167.84K0.10%167.84K$4.25M

Sold Out

HolderChange
Financial gravity asset management-3.00
Creekmur asset management-3.00
Nelson, van denburg & campbell wealth management group-22.00
Bnp paribas arbitrage, snc-33.00
Continuum advisory-34.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2024278-2.11%171,231,529-1.98%901.05%147-3.29%742.78%
Jun 30, 20242841.43%174,683,4282.52%931.02%15211.76%72-15.29%
Mar 31, 20242803.32%170,388,9093.05%950.92%136-5.56%858.97%
Dec 31, 202327110.16%165,339,9663.06%1011.05%14419.01%781.30%
Sep 30, 20232460.82%160,426,3207.13%981.13%12112.04%7726.23%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv4.51M2.38%-23.17K
iShares Russell 2000 ETF3.62M1.92%-8.13K
Vanguard Small Cap Index3.54M1.87%6.90K
SPDR® S&P Biotech ETF2.68M1.43%29.70K
Vanguard Institutional Extnd Mkt Idx Tr2.20M1.16%-16.52K
Vanguard Small Cap Growth Index Inv1.94M1.03%-2.89K
American Funds SMALLCAP World A1.71M0.91%400.00K
Fidelity Small Cap Index1.44M0.76%-36.27K
Pictet-Biotech P USD1.41M0.75%38.08K
Pictet Biotech1.12M0.60%1.12M

Recent Insider Transactions

DateNameRoleActivityValue
Nov 19, 2024Kumar Neil Chief Executive OfficerSell$571.15K
Nov 19, 2024Kumar Neil Chief Executive OfficerSell$42.68K
Nov 19, 2024STEPHENSON BRIAN C Secretary, Treasurer & CFOSell$93.14K
Sep 13, 2024KKR Genetic Disorder L.P.-Sell$149.35M
Aug 19, 2024Kumar Neil Chief Executive OfficerSell$394.89K

Insider Transactions Trends

DateBuySell
2024 Q4-3
2024 Q3-5
2024 Q2-3
2024 Q1-3
2023 Q4-9

BBIO Ownership FAQ

Who Owns BridgeBio Pharma?

BridgeBio Pharma shareholders are primarily institutional investors at 90.83%, followed by 5.40% insiders and 3.77% retail investors. The average institutional ownership in BridgeBio Pharma's industry, Biotech Stocks , is 47.04%, which BridgeBio Pharma exceeds.

Who owns the most shares of BridgeBio Pharma?

BridgeBio Pharma’s largest shareholders are Kohlberg kravis roberts (31.06M shares, 16.56%), Viking global investors lp (25.12M shares, 13.39%), and Vanguard group (14.05M shares, 7.49%). Together, they hold 37.44% of BridgeBio Pharma’s total shares outstanding.

Does Blackrock own BridgeBio Pharma?

Yes, BlackRock owns 6.64% of BridgeBio Pharma, totaling 12.45M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 315.31M$. In the last quarter, BlackRock increased its holdings by 1.98M shares, a 18.93% change.

Who is BridgeBio Pharma’s biggest shareholder by percentage of total assets invested?

Aisling capital management lp is BridgeBio Pharma’s biggest shareholder by percentage of total assets invested, with 66.52% of its assets in 6.07M BridgeBio Pharma shares, valued at 153.71M$.

Who is the top mutual fund holder of BridgeBio Pharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of BridgeBio Pharma shares, with 2.38% of its total shares outstanding invested in 4.51M BridgeBio Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools